Back to the main directory
EarningsReview / Equity
- Elis - Une publication en ligne by MidCap Partners
- U10 - Léger retard, sans conséquence by MidCap Partners
- Infotel - Reprise d’activité confirmée pour le S2 by MidCap Partners
- SANOFI: RDOS. 2T’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- 1H25 results: operationally solid plus US airports disposal by BNP Paribas Exane
- EDP - 2Q25: Small miss, guidance upgraded to consensus by JB Capital Markets
- INVEST SECURITIES - HOPSCOTCH : H1 down and lower guidance, but growth seen in H2 - Buy, TP 27,3€ vs 30€ by Invest Securities
- ALIGN profit warns, calls out patient financing headwind by BNP Paribas Exane
- INVEST SECURITIES - CAPGEMINI : Rassurant, mais visibilité toujours limitée - ACHAT, OC 235€ (vs 232€) by Invest Securities
- INVEST SECURITIES - WORLDLINE : Le chemin de la recovery risque d'être long - SOUS REVUE by Invest Securities
- AB INBEV: RDOS. 2T’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- FCX, AAL, ERA, RIO, MT, OUT1V, APAM, CHINA PMI by BNP Paribas Exane
- VINCI: RDOS. 1S’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- FLUIDRA: RDOS. 1S’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- H125 conf call: FY25e guidance could be an absolute floor across RevPAR, FX, and STO… but July “soft” and no proof point before 2026 now by BNP Paribas Exane
- Making progress by BNP Paribas Exane
- Q4 take-aways from the Q2 conf call by BNP Paribas Exane
- U10 - Slight delay, no impact by MidCap Partners
- Infotel - Confirmed Business Recovery for H2 by MidCap Partners
- Elis - An online publication by MidCap Partners
- H1’25 conf call: Datacentres demand dominates the debate by BNP Paribas Exane
- Q225 conf call: Confident message on H2 by BNP Paribas Exane
- Quid Pro Quo? by BNP Paribas Exane
- H1’25 conf call feedback - highlighting performance by BNP Paribas Exane
- MERLIN PROPERTIES: 1H’25 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell